Stock Analysts

Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook

Vertex Pharmaceuticals Inc.’s ( VRTX ) fourth-quarter 2014 loss came in at 73 cents per share (including stock-based compensation expense), much wider than the year-ago loss of 66 cents and the Zacks Consensus Estimate of a loss of 61 cents. Excluding the impact of stock-based compensation expense, fourth quarter 2014 loss was 55 cents per share as against the year-ago loss of 56 cents per share. […]

Stock Analysts

Coach Q2 Earnings Beat Estimates but Revenue Falls Short

Coach, Inc. ( COH ) posted second-quarter fiscal 2015 earnings of 72 cents a share that came ahead of the Zacks Consensus Estimate of 65 cents thus providing much impetus to the stock that rose 4.2% during pre-market trading hours. The company is undergoing a brand transformation and is introducing modern luxury concept stores in key markets […]

Stock Analysts

Celgene Q4 Earnings & Revenues In Line, Revlimid Sales Up

Celgene Corporation ( CELG ) reported fourth-quarter 2014 earnings of 88 cents per share (including stock-based compensation expenses and tax adjustments), in line with the Zacks Consensus Estimate. The company’s earnings were 64 cents per share in the year-ago quarter. We note that figures have been adjusted to reflect the two-for-one stock split. […]

Stock Analysts

ConocoPhillips Q4 Earnings Miss Estimates, Revenues Beat

ConocoPhillips ( COP ) reported fourth-quarter 2014 adjusted earnings of 60 cents per share, missing the Zacks Consensus Estimate of 62 cents per share and decreasing from the year-earlier profit of $1.40. Revenues in the reported quarter decreased to $11,851.0 million from the year-ago level of $13,985.0 million. However, revenues surpassed the Zacks Consensus Estimate of $11,735.0 million […]

Stock Analysts

Varian Medical Beats Q1 Earnings, Revenues; Outlook Weak

Varian Medical Systems Inc. ( VAR ) reported an impressive first quarter of fiscal 2015, wherein EPS (excluding restructuring charges of 7 cents) of 99 cents surpassed the Zacks Consensus Estimate by 12 cents. EPS (including restructuring charges) increased 1.1% from the year-ago quarter to 92 cents, which comfortably surpassed the company’s guided range of 76 cents to 80 cents. […]

Stock Analysts

PulteGroup Beats on Q4 Earnings & Revenues, Margins Soft

PulteGroup Inc.’s ( PHM ) fourth-quarter 2014 adjusted earnings of 43 cents per share beat the Zacks Consensus Estimate of 41 cents by 4.9%. However, adjusted earnings declined 24.6% from the year-ago figure of 57 cents owing to soft margins. We believe that the earnings beat was driven by strong revenues and lower expenses. […]

Stock Analysts

Hershey Misses Q4 and FY Earnings & Sales, Cuts FY15 View

2014 proved to be a dismal year for The Hershey Company ( HSY ) as the chocolate giant battles with increased competition from broader snacks categories. The chocolate giant missed the Zacks Consensus Estimate for both earnings and revenues in the fourth quarter as well as full-year 2014. Volume losses due to higher prices and greater-than-anticipated currency headwinds hurt results in the quarter. […]

Stock Analysts

Deutsche Bank (DB) Swings to Earnings in Q4, Revenue Up

Deutsche Bank AG ( DB ) reported net income of €441 million ($551 million) in the fourth quarter of 2014, compared with loss of €1.37 billion ($1.86 billion) in the prior-year quarter. Notably, in the reported quarter, the bank recorded income tax benefit of €189 million ($236 million), primarily due to changes in the recognition and measurement of deferred taxes. The bank reported profit before income taxes of €253 million ($316 million), significantly up from a loss of €1.77 billion ($2.41 billion) in the prior-year quarter […]